US stock · Healthcare sector · Medical Distribution
Company Logo

AmerisourceBergen Corporation

ABCNYSE

154.27

USD
+1.19
(+0.78%)
Pre Market
18.82P/E
13Forward P/E
0.73P/E to S&P500
32.314BMarket CAP
1.18%Div Yield
Upcoming Earnings
2 Aug-8 Aug
Shares Short
5/13/22
3.44M
Short % of Float
2.29%
Short % of Shares Outs.
1.64%
% Held by Insiders
25.49%
% Held by Institutions
67.19%
Beta
0.45
PEG Ratio
1.46
52w. high/low
167.19/111.34
Avg. Daily Volume
1.42M
Return %
Stock
S&P 500
1 year
35.21
(6.01)
3 years
91.35
39.24
5 years
69.14
63.25
Scale: |
High
Low
28.28
21.11
24.30
13.33
26.58
13.75
34.72
25.66
43.47
33.91
44.02
35.48
71.38
43.01
92.84
62.55
120.68
89.52
103.40
68.38
97.85
71.90
106.27
69.36
94.75
70.55
111.25
72.06
135.26
94.89
167.19
127.94
Currency: USD
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
TTM
Revenue per share
149.27
178.40
218.47
238.74
276.18
294.41
314.30
380.67
525.89
624.29
692.01
701.29
770.82
854.51
927.29
1,039.19
1,104.36
Earnings per share
1.14
1.27
0.78
1.67
2.26
2.59
2.84
1.88
1.22
(0.62)
6.73
1.67
7.61
4.07
(16.65)
7.48
8.30
FCF per share
1.69
2.94
1.87
2.12
3.27
3.67
4.51
2.53
5.27
16.94
12.79
4.75
4.93
9.68
8.97
10.82
10.46
Dividends per share
0.05
0.10
0.15
0.21
0.32
0.43
0.52
0.85
0.94
1.17
1.36
1.47
1.53
1.61
1.68
1.78
1.81
CAPEX per share
0.28
0.32
0.43
0.49
0.65
0.62
0.65
0.88
1.16
1.06
2.19
2.14
1.54
1.48
1.81
2.13
2.18
Book Value per sh.
10.10
8.37
8.44
9.04
10.47
10.52
9.71
10.04
8.61
2.91
10.03
9.45
13.46
13.70
(4.98)
1.08
1.27
Comm.Shares outs.
410
370
321
301
282
272
253
231
227
218
212
218
218
210
205
206
208
Avg. annual P/E ratio
19.6
19.3
25.1
11.8
13.3
14.9
13.7
30.2
61.5
(168.2)
12.3
51.7
11.6
20.4
(5.7)
15.7
18.8
P/E to S&P500
1.1
1.1
1.2
0.2
0.6
0.9
0.9
1.8
3.4
(8.4)
0.6
2.2
0.5
0.8
(0.1)
0.5
0.7
Avg. annual div. yield
0.2%
0.4%
0.8%
1.1%
1.1%
1.1%
1.4%
1.5%
1.3%
1.1%
1.6%
1.7%
1.7%
1.9%
1.8%
1.5%
1.4%
Revenue (m)
61,203
66,074
70,190
71,760
77,954
80,218
79,490
87,959
119,569
135,962
146,850
153,144
167,940
179,589
189,894
213,989
229,666
Operating margin
1.2%
1.2%
1.2%
1.2%
1.4%
1.5%
1.6%
1.0%
0.7%
0.3%
1.0%
0.7%
0.9%
0.6%
(2.7)%
1.1%
1.1%
Depreciation (m)
97
104
96
94
104
126
147
171
193
250
392
432
510
498
408
515
665
Net profit (m)
468
469
251
503
637
707
719
434
276
(135)
1,428
364
1,658
855
(3,409)
1,540
1,727
Income tax rate
36.8%
37.1%
38.4%
37.9%
38.0%
37.5%
39.1%
40.2%
57.8%
149.2%
(2.7)%
60.3%
(37.2)%
11.7%
35.8%
30.5%
29.5%
Net profit margin
0.8%
0.7%
0.4%
0.7%
0.8%
0.9%
0.9%
0.5%
0.2%
(0.1)%
1.0%
0.2%
1.0%
0.5%
(1.8)%
0.7%
0.7%
Working capital (m)
1,751
857
502
474
842
363
(227)
(477)
(450)
(2,366)
(2,429)
(2,515)
(1,975)
(1,449)
(797)
(2,556)
(3,388)
Long-term debt (m)
1,094
1,227
1,187
1,177
1,343
973
1,447
1,397
1,996
3,493
3,594
3,430
4,159
4,034
3,618
6,384
4,647
Equity (m)
4,141
3,100
2,710
2,716
2,954
2,867
2,457
2,320
1,957
634
2,129
2,064
2,933
2,879
(1,019)
223
550
ROIC
8.8%
10.7%
8.3%
13.3%
15.1%
18.3%
18.3%
12.4%
7.3%
(3.7)%
18.8%
5.0%
20.0%
10.8%
(32.3)%
10.7%
13.3%
Return on capital
5.8%
6.2%
4.4%
6.4%
7.6%
8.1%
8.2%
4.4%
3.5%
1.4%
4.6%
3.0%
3.8%
3.0%
(11.7)%
4.2%
4.7%
Return on equity
11.3%
15.1%
9.2%
18.5%
21.6%
24.6%
29.3%
18.7%
14.1%
(21.3)%
67.1%
17.7%
56.5%
29.7%
334.5%
689.5%
313.8%
Plowback ratio
95.6%
92.1%
80.6%
87.5%
85.8%
83.4%
81.5%
54.9%
22.4%
288.2%
79.8%
12.1%
79.9%
60.4%
110.1%
76.2%
76.7%
Div.&Repurch./FCF
86.7%
126.5%
107.5%
80.4%
60.7%
95.8%
113.5%
116.1%
80.8%
- -
94.1%
62.7%
90.4%
49.8%
- -
20.1%
18.5%
Capital Structure
4 May · 2022 | Q2
All numbers in millions
Total liabilities
$ 56,402
Total assets
$ 57,308
Long-term debt
$ 4,647
Cash and equiv.
$ 2,961
Goodwill
$ 8,798
Retained earnings
$ 2,470
Common stock
209
Enterprise Value
$ 34,000
Working Capital
Currency: USD, in millions
2019
2020
2021
Cash & Investments
3,374
4,598
2,547
Receivables
12,387
14,335
18,389
Inventory
11,060
12,589
15,368
Other
1,311
2,758
1,671
Current assets
28,132
33,056
38,803
Acc. Payable
28,385
31,705
38,010
Debt due
139
501
300
Other
1,057
1,647
3,048
Current liabilities
29,581
33,853
41,359
Annual growth rates
(avg. rate of change)
1 year
5 years
10 years
Revenue
12.69%
8.76%
11.96%
Cash flow
21.28%
26.10%
31.10%
Earnings
(145.18)%
(84.28)%
(199.43)%
Dividends
6.71%
3.46%
12.65%
Book value
(121.92)%
(54.27)%
(8.10)%
Insider Trading
Type
Shares
Date
Walgreens Boots Alliance, Inc.
Sale
6.00mln.
05/11/22
Krikorian Lazarus
Sale
4,895
05/11/22
Krikorian Lazarus
Exempt
6,654
05/10/22
Krikorian Lazarus
Sale
105
05/10/22
Krikorian Lazarus
Sale
6,654
05/10/22
Quarterly Revenue
Currency: USD, in millions
Year
1Q
2Q
3Q
4Q
Total
2020
47,865
47,418
45,367
49,245
189,894
2021
52,517
49,154
53,406
58,912
213,989
2022
59,629
57,719
- -
- -
- -
Earnings per share
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
0.92
4.69
1.41
(23.66)
(16.65)
2021
1.82
2.11
1.42
2.13
7.48
2022
2.15
2.62
- -
- -
- -
Quarterly dividends paid
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
0.41
0.43
0.42
0.42
1.68
2021
0.44
0.44
0.45
0.45
1.78
2022
0.48
- -
- -
- -
- -
Company Description
Sector:
Healthcare
Industry:
Medical Distribution
CEO:
Mr. Steven Collis
Full-time employees:
38,000
City:
Chesterbrook
Address:
1300 Morris Dr
IPO:
Dec 16, 1993
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Recent News